Many users of a common asthma inhaler are poised to lose it in the new year, possibly due to changes to Medicaid rebate rules from the Biden administration.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
